Written by While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related adverse events (irAEs)—side effects that can impact almost every organ in the body to varying degrees. The frequency and severity of irAEs in real-world datasets are not well understood, making it difficult to combine cases effectively across institutions and gain insights into the optimal management of these patients.
Medical Xpress – latest medical and health news stories